North Growth Management Ltd. Gilead Sciences, Inc. Transaction History

North Growth Management Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$64.88 - $73.64 $9.21 Million - $10.5 Million	-142,000 Closed	0 $0
Q2 2021 Jul 15, 2021	BUY	$63.47 - $69.35 $63,470 - $69,350	1,000 Added 0.71%	142,000 $9.76 Million
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $623,150 - $710,050	-11,000 Reduced 7.24%	141,000 $8.23 Million
Q3 2020 Nov 04, 2020	BUY	$62.1 - $78.08 $931,500 - $1.17 Million	15,000 Added 10.95%	152,000 $9.59 Million
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $361,700 - $420,000	-5,000 Reduced 3.52%	137,000 $10.6 Million
Q1 2020 May 08, 2020	SELL	$62.63 - $80.22 $2.07 Million - $2.65 Million	-33,000 Reduced 18.86%	142,000 $10.6 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $937,650 - $1.04 Million	15,000 Added 9.38%	175,000 $11.1 Million
Q2 2018 Aug 10, 2018	BUY	$64.88 - $75.68 $1.17 Million - $1.36 Million	18,000 Added 12.68%	160,000 $11.3 Million
Q4 2017 Aug 10, 2018	BUY	$71.15 - $83.52 $10.1 Million - $11.9 Million	142,000	142,000 $10.2 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of North Growth Management Ltd., based on Form 13F filings with the SEC.

Stay updated on North Growth Management Ltd. with notifications on news.